ARTICLE | Clinical News
Durezol regulatory update
July 30, 2012 7:00 AM UTC
Novartis disclosed in its 2Q12 earnings that FDA approved an sNDA for Durezol difluprednate treat endogenous anterior uveitis. The topical ophthalmic emulsion containing difluprednate is already marke...